Mark Schoenberg - 31 Jan 2026 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Medical Officer
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
31 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 17:18:26 UTC
Previous filing
20 Nov 2025
Next filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schoenberg Mark Chief Medical Officer 400 ALEXANDER PARK DRIVE, PRINCETON /s/ Jason D. Smith, Attorney-in-Fact 03 Feb 2026 0001763581

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +3,333 +2.3% 145,692 31 Jan 2026 Direct F1
transaction URGN Ordinary Shares Options Exercise +6,666 +4.6% 152,358 31 Jan 2026 Direct F1
transaction URGN Ordinary Shares Options Exercise +3,334 +2.4% 142,359 31 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -3,333 -50% $0.000000 3,334 31 Jan 2026 Ordinary Shares 3,333 Direct F1, F4
transaction URGN Restricted Stock Units Options Exercise $0 -6,666 -33% $0.000000 13,334 31 Jan 2026 Ordinary Shares 6,666 Direct F1, F2
transaction URGN Restricted Stock Units Options Exercise $0 -3,334 -100% $0.000000 0 31 Jan 2026 Ordinary Shares 3,334 Direct F1, F3
transaction URGN Restricted Stock Units Award $0 +20,000 $0.000000 20,000 31 Jan 2026 Ordinary Shares 20,000 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2 The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.
F3 The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
F4 The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.
F5 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.